Research Roundup


Debbie Rigby rounds up the latest in research news Reduced treatment response to inhaled corticosteroids in current smokers with COPD Inhaled corticosteroids benefit patients with chronic obstructive pulmonary disease at high risk of exacerbations with raised blood eosinophil count. Emerging evidence suggests current smokers show a reduced response to ICS. in current smokers with COPD,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘We are unashamedly backing community pharmacists’
Next Dog bites man, man sentenced